FDA Drug Application (020884) for AGGRENOX by BOEHRINGER INGELHEIM

Back to FDA Applications sponsored by BOEHRINGER INGELHEIM

Application Number020884
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage25MG;200MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameAGGRENOX
Active IngredientASPIRIN; DIPYRIDAMOLE

Active IngredientCount
List of drugs with Active Ingredient ASPIRIN60
List of drugs with Active Ingredient DIPYRIDAMOLE6


Back to FDA Applications sponsored by BOEHRINGER INGELHEIM